| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 1,353,711 | 1,549,765 | 1,465,323 | | Cost of Revenue | 1,412,851 | 1,397,038 | 1,338,155 | | | Gross Profit | (59,140) | 152,727 | 127,168 | | | Operating Expenses | | Research Development | 102,240 | 97,034 | 94,171 | | Selling General and Administrative | 79,502 | 93,206 | 65,596 | | Non Recurring | 103,863 | (28,651) | (43,122) | | Others | 32,191 | 27,071 | 24,394 | | | | Total Operating Expenses | 317,797 | 188,659 | 141,038 | | | | Operating Income or Loss | (376,937) | (35,932) | (13,870) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 22,201 | 25,836 | (5,175) | | Earnings Before Interest And Taxes | (354,736) | (10,095) | (19,045) | | Interest Expense | 50,767 | 37,936 | 50,926 | | Income Before Tax | (405,503) | (48,032) | (69,971) | | Income Tax Expense | 26,433 | (29,720) | (24,928) | | Minority Interest | (7,851) | 2,856 | (19) | | | | Net Income From Continuing Ops | (440,231) | (19,468) | (49,263) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| 5,154 | | Other Items |
-
|
-
|
-
| | | | Net Income | (440,231) | (19,468) | (44,109) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($440,231) | ($19,468) | ($44,109) |
|
0.51% Nasdaq 
Income Statement
